PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-432.04
Negative P/E while CRON.TO shows 244.80. Joel Greenblatt would examine path to profitability versus competitor.
875.32
P/S 50-75% of CRON.TO's 1277.71. Bruce Berkowitz would examine if sales quality justifies the gap.
17.27
P/B 50-75% of CRON.TO's 23.32. Bruce Berkowitz would examine if asset composition explains the gap.
-152.06
Both companies show negative FCF. Martin Whitman would check for industry-wide capital intensity issues.
-151043.78
Both companies show negative operating cash flow. Martin Whitman would check for industry-wide operational issues.
17.27
Fair value ratio 50-75% of CRON.TO's 23.32. Bruce Berkowitz would examine if business quality explains the gap.
-0.06%
Negative earnings while CRON.TO shows yield of 0.10%. Joel Greenblatt would examine path to profitability.
-0.66%
Both companies show negative FCF. Martin Whitman would check for industry-wide capital intensity issues.